Related Experiment Videos
Clinical protocols for the application of tests for circulating tumor markers
1Divisione di Medicina Nucleare, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano.
Annali Dell'Istituto Superiore Di Sanita
|January 1, 1991
Summary
Interpreting circulating tumor marker levels requires a dynamic approach, considering individual variations and integrating results with other clinical data for accurate cancer assessment. Periodic testing is crucial for monitoring treatment response and detecting recurrence.
Area of Science:
- Biochemistry
- Oncology
- Clinical Diagnostics
Background:
- Circulating tumor markers are vital in cancer diagnostics but require careful interpretation.
- Test results, often expressed as concentrations, represent tumor activity and are not absolute values.
Purpose of the Study:
- To outline a strategic approach for applying circulating marker level determination in clinical practice.
- To emphasize the importance of dynamic interpretation and integration of marker data with other clinical information.
Main Methods:
- Interpreting marker results as dynamic variations over time, referencing previous values.
- Periodically repeating marker determinations for treatment response evaluation and recurrence detection.
- Integrating laboratory findings with clinical and instrumental data for comprehensive neoplasm assessment.
Main Results:
- Single marker measurements can indicate tumor extent and growth but lack value if isolated.
- Dynamic interpretation and integration with clinical data enhance the utility of marker levels.
- Considering biological variables (age, sex, organ function, lifestyle) is essential for accurate interpretation.
Conclusions:
- A standardized, codified procedural logic is necessary for each neoplasm to effectively utilize circulating marker data.
- Effective use of circulating tumor markers demands a strategic application, dynamic interpretation, and holistic integration with patient data.